Sterne Agee is the lead agent and Maxim Group is co-placement agent
By Devika Patel
Knoxville, Tenn., Nov. 20 – Viveve Medical, Inc. said it will raise about $6 million in a private placement of stock.
The company will sell about 8.6 million common shares at $0.70 apiece. The per-share price represents a 1.45% premium to the Nov. 19 closing share price of $0.69.
Sterne Agee CRT is the lead agent, and Maxim Group LLC is co-placement agent.
Proceeds will be used for the commercial launch of the Viveve System.
Based in Sunnyvale, Calif., Viveve is a medical device company.
| Issuer: | Viveve Medical, Inc.
|
| Issue: | Common stock
|
| Amount: | $6 million (approximate)
|
| Shares: | 8.6 million (approximate)
|
| Price: | $0.70
|
| Warrants: | No
|
| Agents: | Sterne Agee CRT (lead) and Maxim Group LLC (co-placement agent)
|
| Pricing date: | Nov. 20
|
| Stock symbol: | OTCBB: VIVMF
|
| Stock price: | $0.69 at close Nov. 19
|
| Market capitalization: | $34.4 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
